Adacel, Tdap vaccine, receives FDA approval for expanded use

The U.S. Food and Drug Administration has approved the expanded use of Adacel(R) (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat vaccination to help protect against tetanus, diphtheria and pertussis. It is now the first and only Tdap vaccine in the U.S. approved for a repeat dose in people 10 ["]

The post Adacel, Tdap vaccine, receives FDA approval for expanded use appeared first on Outbreak News Today.